Dr. Klumpp has over 15 years of senior management experience in large pharma and biotech organizations and has supported large and small molecule programs through all stages of development from discovery through IND, NDA, and post-approval product support. He previously served as Vice President and Global Head of Virology Discovery at Roche. While at Roche, Dr. Klumpp was involved in establishing development programs in the areas of HIV, influenza, Hepatitis B, and C. Five antiviral products were approved during that time. He also contributed to multiple discovery-to-INDs, and Ph1-to-Ph2 transitions, achieving clinical proof of concept and successful exits with biotech companies in the areas of Hepatitis B, HIV, influenza, SARS-CoV-2, and obesity at Novira Therapeutics Inc., Viriom Inc., Savira Pharmaceuticals GmbH, Biotron Ltd., and Bioage Labs Inc.